19 studies found for:    Open Studies | "Respiratory Syncytial Virus Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Respiratory Syncytial Virus Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Study to Evaluate Antiviral Activity, Safety, and Pharmacokinetics of Repeated Doses of Orally Administered JNJ 53718678 Against Respiratory Syncytial Virus Infection
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: Placebo;   Drug: JNJ-53718678
2 Unknown  The Development of a Human Model of Respiratory Syncytial Virus Infection
Conditions: Respiratory Syncytial Virus Infections;   Respiratory Viral Infections
Intervention: Biological: RSV A Memphis 37
3 Not yet recruiting Study to Evaluate the Efficacy and Safety of REGN2222, for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants
Condition: Respiratory Syncytial Virus Infections
Intervention: Drug: REGN2222
4 Recruiting Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
Conditions: Lower Respiratory Tract Infection;   Respiratory Syncytial Virus Infections
Intervention:
5 Recruiting Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immuno Compromised Children With Synagis
Condition: Respiratory Syncytial Virus Infection
Intervention:
6 Recruiting A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171
Condition: Respiratory Syncytial Virus Infection
Interventions: Biological: ALX-0171;   Other: Placebo
7 Recruiting RSV Observational Study 2
Condition: Respiratory Syncytial Virus Infections
Intervention: Procedure: Blood sample
8 Recruiting Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV MEDI ΔM2-2 vaccine;   Biological: Placebo vaccine
9 Recruiting Safety, Tolerability and PK Study of AK0529 in Healthy Human
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: AK0529;   Drug: Placebo
10 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV ΔNS2 Δ1313 I1314L Vaccine;   Biological: Placebo (1x Leibovitz L-15 medium)
11 Recruiting Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV cps2 Vaccine;   Biological: Placebo Vaccine
12 Unknown  Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
Conditions: Respiratory Distress Syndrome, Adult;   Respiratory Syncytial Virus Infections;   Pneumonia;   Acute Lung Injury
Intervention:
13 Recruiting Prospective, Study for the Use of Palivizumab (Synagis) in High Risk Children in Germany
Condition: Respiratory Syncytial Virus Infections
Intervention:
14 Recruiting Respiratory Syncytial Virus - RSV Protocol
Conditions: Bone Marrow Transplant Infection;   Infection in Marrow Transplant Recipients;   Respiratory Syncytial Virus Infections;   Respiratory Syncytial Virus Pneumonia;   Cancer;   Acute Leukemia
Intervention: Drug: Ribavirin
15 Recruiting A Study of ALS-008176 in Infants Hospitalized With RSV
Condition: Respiratory Syncytial Virus Infections
Interventions: Drug: ALS-008176;   Drug: Placebo
16 Recruiting GS-5806 in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
Condition: Respiratory Syncytial Virus
Interventions: Drug: GS-5806;   Drug: Placebo
17 Recruiting Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression
Condition: Infections, Respiratory Syncytial Virus
Interventions: Drug: Danirixin;   Other: CXCL1
18 Recruiting TGF-(Beta) and Susceptibility to RSV
Conditions: Respiratory Syncytial Virus;   Asthma
Intervention:
19 Unknown  RSV Disease in the Elderly
Conditions: Respiratory Infections, Acute;   Respiratory Syncytial Virus
Intervention:

Indicates status has not been verified in more than two years